Form D · Biotechnology
Promaxo Holdings, Inc.
Oakland, CA · CIK 0002125200
Offering snapshot reported Mar 30, 2026 · SEC filing
- Reported sold
- $26.8M Offering amount: $28.8M
- Investors reported
- 118 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Mar 17, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 30, 2026 | Initial | $26,848,795 | No comparison | 118 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-578328
$3,831,236 of the Total Amount Sold consisted of principal and interest in converting promissory notes and $359,993 of the Total Amount Sold was issued in exchange for payment of certain invoices.
Source: Form D, filed Mar 30, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Bartholomew | Executive |
| Dushyant Chipalkatty | Director |
| Derek Hennecke | Director |
| Srirama Venkataraman | Executive |
| Amit Vohra | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
70 Washington St Ste 407
Oakland, CA, 94607
Oakland, CA, 94607